Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
scPharmaceuticals, Inc. (SCPH) had Return on Tangible Equity of 84.56% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$16.04M |
|
$-18.02M |
|
$5.01M |
|
$11.03M |
|
$30.34M |
|
$-14.29M |
|
$-3.73M |
|
$-18.02M |
|
$-18.02M |
|
$-18.02M |
|
$-18.02M |
|
$-18.02M |
|
$-18.02M |
|
$-14.29M |
|
$-14.23M |
|
53.72M |
|
53.72M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$78.73M |
|
$0.05M |
|
$1.53M |
|
$80.25M |
|
$20.43M |
|
$51.20M |
|
$81.14M |
|
$101.57M |
|
$-21.32M |
|
$-21.32M |
|
$-21.32M |
|
53.29M |
|
| Cash Flow Statement Financials | |
$-33.25M |
|
-- |
|
$-1.60M |
|
$75.66M |
|
$40.81M |
|
$-34.85M |
|
$2.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.85 |
|
-- |
|
-- |
|
1.71 |
|
-2.40 |
|
68.76% |
|
-89.11% |
|
-89.11% |
|
-- |
|
-112.36% |
|
-112.36% |
|
$-33.25M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.34 |
|
0.83 |
|
108.90 |
|
84.56% |
|
|
Return on Tangible Equity |
84.56% |
-22.46% |
|
-60.31% |
|
$-0.40 |
|
$-0.62 |
|
$-0.62 |
|